Pharmaceuticals Dietary Supplements Dietary Interventions Postpartum Health Medical Studies Oncology Oral Health Treatment Strategies Investigative Journalism Ethics
Participants in the 26-week ADJUST-T1D trial experienced significant gains in target blood sugar range alongside substantial weight loss with weekly semaglutide.